Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm.

Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm.

Dosage regimens should generally be individualised, depending on features of the patient that can alter the drug's pharmacokinetics (disposition in the body) or pharmacodynamics (therapeutic and adverse effects). It is usually good practice to start with a low dose, gradually increasing it acco...

書誌詳細
第一著者:	Aronson, J
フォーマット:	Journal article
言語:	English
出版事項:	2005

類似資料

Assessing perceptions of benefit and harm of common drug therapies using therapeutic scenarios
著者:: Aronson, J, 等
出版事項: (2003)

Inhibiting the proton pump: mechanisms, benefits, harms, and questions
著者:: Aronson, J
出版事項: (2016)

Balancing benefits and harms in health care.
著者:: Cuervo, L, 等
出版事項: (2003)

Lorcaserin in obesity: minimal benefits and ill-defined harms
著者:: Onakpoya, I, 等
出版事項: (2019)

ON THE SELECTION OF DRUGS DOSAGE REGIMEN
著者:: E. N. Bochanova
出版事項: (2015-09-01)

ON THE SELECTION OF DRUGS DOSAGE REGIMEN
著者:: E. N. Bochanova
出版事項: (2015-09-01)

Patentability of Pharmaceutical Dosage Regimens in Europe
著者:: Mahdi Zahedi, 等
出版事項: (2013-03-01)

Application of Monte Carlo simulation to optimise the dosage regimen of meropenem in patients with augmented renal clearance for Pseudomonas aeruginosa infection
著者:: Jia Hou, 等
出版事項: (2024-06-01)

Increasing Risks to the Health of the Invertebrates—Balancing between Harm and Benefit
著者:: Tatiana V. Kuznetsova, 等
出版事項: (2024-05-01)

ChatGPT and mental healthcare: balancing benefits with risks of harms
著者:: John Torous, 等
出版事項: (2023-10-01)

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment
著者:: Bruce Leff, 等
出版事項: (2019-08-01)

Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesis.
著者:: Ferner, R, 等
出版事項: (2013)

The appropriate use of human albumin in a Brazilian University Hospital: therapeutic indication and dosage regimen
著者:: Tatiane Sayuri Ishida, 等
出版事項: (2019-04-01)

Suicide, depression, and antidepressants - Patients and clinicians need to balance benefits and harms
著者:: Cipriani, A, 等
出版事項: (2005)

Predicted Vancomycin Dosage Requirement in Patients With Hematological Malignancies and Dosage Dynamic Adjustment
著者:: Xiangqing Song, 等
出版事項: (2022-06-01)

Monitoring for harms of therapy.
著者:: Aronson, J
出版事項: (2006)

Individualized antibiotic dosage regimens for patients with augmented renal clearance
著者:: A-Xi Shi, 等
出版事項: (2023-07-01)

Optimizing vancomycin dosage regimen at the University Medical Center Maribor
著者:: Maja Cvikl, 等
出版事項: (2011-12-01)

DISPOSITION KINETICS AND DOSAGE REGIMEN OF INTRAVENOUSLY INJECTED KANAMYCIN IN BUFFALOES
著者:: T. Saeed, R. Ahmad, M. Nawaz1 and T. Iqbal
出版事項: (2000-01-01)

Dosage regimen and toxicity risk assessment of linezolid in sepsis patients
著者:: Linjie Dou, 等
出版事項: (2020-07-01)

Dosage adjustment in renal insufficiency: comparison between databases
著者:: Isabella Faria MARANHÃO, 等
出版事項: (2024-03-01)

Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage
著者:: M. de Jong, 等
出版事項: (2023-12-01)

Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective
著者:: Myriam Briki, 等
出版事項: (2023-04-01)

Adverse drug reactions--no farewell to harms.
著者:: Aronson, J
出版事項: (2007)

Scheduled dosage regimen by irreversible electroporation of loaded erythrocytes for cancer treatment
著者:: Wencheng Peng, 等
出版事項: (2023-12-01)

Population Pharmacokinetic Modeling of Zaltoprofen in Healthy Adults: Exploring the Dosage Regimen
著者:: Ji-Hun Jang, 等
出版事項: (2023-01-01)

Chloroquine dosage regimen simulation for pediatric patients with coronavirus disease 2019
著者:: Kiatkriangkrai Koyratkoson, 等
出版事項: (2022-07-01)

Market harms and market benefits
著者:: Wilkinson, H
出版事項: (2022)

Balance between solitude and socializing: everyday solitude time both benefits and harms well-being
著者:: Netta Weinstein, 等
出版事項: (2023-12-01)

Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen
著者:: Natasha Strydom, 等
出版事項: (2024-08-01)

Optimising dosage of Lytag used as coarse aggregate in lightweight aggregate concretes
著者:: S Ahmad, 等
出版事項: (2013-04-01)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
著者:: Onakpoya, I, 等
出版事項: (2018)

Optimisation of BMP-2 dosage for the osseointegration of porous titanium implants in an ovine model
著者:: EB Hunziker, 等
出版事項: (2016-11-01)

Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen
著者:: A. I. Kochetkov, 等
出版事項: (2019-09-01)

Individualization of the Dosage Regimen of Erythropoietin is Crucial in End-stage Renal Disease Patients
著者:: M. K. Krishnapriya, 等
出版事項: (2023-03-01)

A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis
著者:: Jung JA, 等
出版事項: (2015-09-01)

Influence of potential gene polymorphisms on propofol dosage regimen in patients undergoing abdominal hysterectomy
著者:: Ivanov E, 等
出版事項: (2021-03-01)

Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits
著者:: Patrícia Soares Silva Montagner, 等
出版事項: (2023-08-01)

Critical Overview on the Benefits and Harms of Aspirin
著者:: Chun Shing Kwok, 等
出版事項: (2010-05-01)

Dietary Supplements in Childhood — Harm or Benefit?
著者:: Anatoly I. Khavkin, 等
出版事項: (2025-02-01)